Arlinda Lee


UPDATE: MLV Raises TG Therapeutics Price Target Following TG-1101 And TGR-1202 Data At ASH

In a research report released this morning, MLV analyst Arlinda Lee maintained a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a price target …

MLV Reiterates Buy On Agios Pharmaceuticals Following AG-221 Clinical Data Release

In a research report published Wednesday, MLV analyst Arlinda Lee reiterated a Buy rating on Agios Pharmaceuticals (NASDAQ:AGIO) with a price target of …

Agios Pharmaceuticals: We Expect Multiple Catalysts To Support The Stock, Says MLV

In a research report issued today, MLV analyst Arlinda Lee initiated coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy rating and a $123 price …

MLV Reiterates Buy On Lpath Following 3Q Earnings Update

In a research report sent to investors today, MLV analyst Arlinda Lee reiterated a Buy rating on Lpath Inc (NASDAQ:LPTN) with a $11 price …

MLV Reiterates Buy On TG Therapeutics Following 3Q14 Update

MLV analyst Arlinda Lee reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $16 price target, as the company reported third- quarter earnings of ($0.51) …

MLV Reiterates Buy On pSivida As All Eyes On Iluvien US Launch

In a research report issued today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 price target, following …

MLV Reduced MannKind Price Target On A Detailed Review Of The Capital Structure

In a research report published today, MLV analyst Arlinda Lee maintained a Hold rating on MannKind Corporation (NASDAQ:MNKD), while reducing her price target to $7 …

MLV Initiates Buy On Xencor, Sees 46% Upside For The Stock

In a research report released today, MLV analyst Arlinda Lee initiated coverage on shares of Xencor (NASDAQ:XNCR) with a Buy rating and a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts